Circulating tumor DNA (ctDNA) as a tool to help guide germline testing in patients with solid malignancies.
2021
10602Background: As the use of circulating tumor DNA (ctDNA) is more widely implemented, incidental identification of pathogenic variants reflecting germline alterations in cancer predisposition ge...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI